| Issue Date | Title | Author(s) |
| 2009 | Activated platelets and coagulation in patients on haemodialysis | Milburn, James A.; Cassar, Kevin; Ford, Isobel; Fluck, Nicholas; Brittenden, Julie |
| 2003 | Are national cardiac guidelines being applied by vascular surgeons? | Cassar, Kevin; Belch, Jill J. F.; Brittenden, Julie |
| 2002-06 | Audit of general practitioners' referral policy and risk factor management in patients with intermittent claudication | Cassar, Kevin; Coull, Robbie; Bachoo, Paul; Macaulay, E. M.; Brittenden, Julie |
| 2005 | Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty | Cassar, Kevin; Bachoo, Paul; Ford, Isobel; Greaves, Mike; Brittenden, Julie |
| 2007 | Completing the audit cycle : comparison of cardiac risk factor management in patients with intermittent claudication in two time periods | Wilson, Alasdair M.; Bachoo, Paul; Mackay, Ian A.; Cassar, Kevin; Brittenden, Julie |
| 2004 | Double-blind randomized placebo-controlled trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone at endovascular intervention for intermittent claudication of the lower limb | Cassar, Kevin; Bachoo, Paul; Ford, Isobel; Greaves, Mike; Brittenden, Julie |
| 2003 | The effect of peripheral percutaneous transluminal angioplasty on quality of life in patients with intermittent claudication | Cassar, Kevin; Bachoo, Paul; Brittenden, Julie |
| 2004 | Helicobacter pylori seropositivity is associated with enhanced platelet activation in patients with intermittent claudication | Cassar, Kevin; Bachoo, Paul; Ford, Isobel; McGee, Magnus; Greaves, Mike; Brittenden, Julie |
| 2009 | Introducing endovenous laser therapy ablation to a national health service vascular surgical unit e the aberdeen experience | MacKenzie, Rhoda K.; Cassar, Kevin; Brittenden, Julie; Bachoo, Paul |
| 2003 | Management of secondary risk factors in patients with intermittent claudication | Cassar, Kevin; Coull, Robbie; Bachoo, Paul; Macaulay, E. M.; Brittenden, Julie |
| 2005 | Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease | Cassar, Kevin; Bachoo, Paul; Ford, Isobel; Greaves, Michael; Brittenden, Julie |
| 2003 | Platelet activation is increased in peripheral arterial disease | Cassar, Kevin; Bachoo, Paul; Ford, Isobel; Greaves, Michael; Brittenden, Julie |
| 2012 | Platelet activation, coagulation activation and C-reactive protein in simultaneous samples from the vascular access and peripheral veins of haemodialysis patients | Milburn, James A.; Ford, Isobel; Cassar, Kevin; Fluck, Nicholas; Brittenden, Julie |
| 2008 | Platelet function in patients with end-stage renal failure undergoing haemodialysis | Milburn, James; Cassar, Kevin; Ford, Isobel; Fluck, Nicholas; Brittenden, Julie |
| 2003 | Platelet P-selectin expression is associated with helicobacter pylori seropositivity in patients with peripheral arterial disease | Ford, Isobel; Cassar, Kevin; Bachoo, Paul; Mitchell, Lloyd; Greaves, Michael; Brittenden, Julie |
| 2011 | Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis | Milburn, James A.; Cassar, Kevin; Ford, Isobel; Fluck, Nicholas; Brittenden, Julie |
| 2009 | Pro‐thrombotic changes in platelet, endothelial and coagulation function following haemodialysis | Milburn, James A.; Cassar, Kevin; Ford, Isobel; Fluck, Nicholas; Brittenden, Julie |
| 2005 | Randomized clinical trial of the antiplatelet effects of aspirin–clopidogrel combination versus aspirin alone after lower limb angioplasty | Cassar, Kevin; Ford, Isabel; Greaves, Mike; Bachoo, Paul; Brittenden, Julie |
| 2003 | The role of platelets in peripheral vascular disease | Cassar, Kevin; Bachoo, Paul; Brittenden, Julie |
| 2006 | Variability in responsiveness to clopidogrel in patients with intermittent claudication | Cassar, Kevin; Bachoo, Paul; Ford, Isobel; Greaves, Michael; Brittenden, Julie |
